Mouse Anti-MCFD2 (AA 1-146) Recombinant Antibody (CBFYM-1869) (CBMAB-M2040-FY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Vesicle-mediated transport Source: UniProtKB-KW
Golgi apparatus
Other locations
Endoplasmic reticulum-Golgi intermediate compartment
A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-MCFD2 Recombinant Antibody (3A5-G4) (CAT#: CBMAB-A5341-LY)
Mouse Anti-MCFD2 Recombinant Antibody (CBFYM-0064) (CAT#: CBMAB-M0072-FY)
Rat Anti-MCFD2 Recombinant Antibody (CBXS-1757) (CAT#: CBMAB-S4579-CQ)
Mouse Anti-MCFD2 Recombinant Antibody (X1) (CAT#: CBMAB-A5342-LY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
